CNCE

Concert Pharmaceuticals, Inc.

Delisted

CNCE was delisted on the 3rd of March, 2023.

80 hedge funds and large institutions have $227M invested in Concert Pharmaceuticals, Inc. in 2022 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 33 increasing their positions, 17 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
80
Holders Change
+10
Holders Change %
+14.29%
% of All Funds
1.38%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
19
Increased
33
Reduced
17
Closed
9
Calls
$1.12M
Puts
$105K
Net Calls
+$1.01M
Net Calls Change
+$464K
Name Holding Trade Value Shares
Change
Shares
Change %
SPIA
76
Steward Partners Investment Advisory
New York
$13K
Royal Bank of Canada
77
Royal Bank of Canada
Ontario, Canada
$5K +$4.77K +843 +2,108%
Wells Fargo
78
Wells Fargo
California
$2K +$762 +109 +62%
DBG
79
De Burlo Group
Massachusetts
$1.34K +$1.34K +200 New
AWM
80
AllSquare Wealth Management
New York
$1K
Walleye Capital
81
Walleye Capital
New York
-$840K -199,500 Closed
Marshall Wace
82
Marshall Wace
United Kingdom
-$374K -89,146 Closed
VF
83
Virtu Financial
New York
-$275K -65,416 Closed
PVI
84
Pura Vida Investments
New York
-$187K -44,357 Closed
XT
85
XTX Topco
Cayman Islands
-$125K -29,766 Closed
D.E. Shaw & Co
86
D.E. Shaw & Co
New York
-$109K -25,901 Closed
CCM
87
CAAS Capital Management
New York
-$49K -11,534 Closed
Squarepoint
88
Squarepoint
New York
-$47K -11,265 Closed
CAPTRUST Financial Advisors
89
CAPTRUST Financial Advisors
North Carolina
-$6K -1,394 Closed